Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 3521453, 10 pages
http://dx.doi.org/10.1155/2016/3521453
Research Article

Annexin A2 Coordinates STAT3 to Regulate the Invasion and Migration of Colorectal Cancer Cells In Vitro

1Department of Radiology, China-Japan Union Hospital, Jilin University, Changchun 130033, China
2Department of Ultrasonography, China-Japan Union Hospital, Jilin University, Changchun 130033, China
3China-Japan Union Hospital, Jilin University, Changchun 130033, China

Received 16 October 2015; Revised 11 February 2016; Accepted 24 March 2016

Academic Editor: Massimo Pancione

Copyright © 2016 Dianhui Xiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2006,” CA: A Cancer Journal for Clinicians, vol. 56, no. 2, pp. 106–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. S. Denlinger and P. F. Engstrom, “Colorectal cancer survivorship: movement matters,” Cancer Prevention Research, vol. 4, no. 4, pp. 502–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. P. Medema and L. Vermeulen, “Microenvironmental regulation of stem cells in intestinal homeostasis and cancer,” Nature, vol. 474, no. 7351, pp. 318–326, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Terzic, S. Grivennikov, E. Karin, and M. Karin, “Inflammation and colon cancer,” Gastroenterology, vol. 138, no. 6, pp. 2101–2114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Jarnicki, T. Putoczki, and M. Ernst, “Stat3: linking inflammation to epithelial cancer—more than a ‘gut’ feeling?” Cell Division, vol. 5, article 14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. E. Levy and C.-K. Lee, “What does Stat3 do?” The Journal of Clinical Investigation, vol. 109, no. 9, pp. 1143–1148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Yu, M. Kortylewski, and D. Pardoll, “Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment,” Nature Reviews Immunology, vol. 7, no. 1, pp. 41–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Yu and R. Jove, “The STATs of cancer—new molecular targets come of age,” Nature Reviews Cancer, vol. 4, no. 2, pp. 97–105, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. K. A. Hajjar and S. Krishnan, “Annexin II: a mediator of the plasmin/plasminogen activator system,” Trends in Cardiovascular Medicine, vol. 9, no. 5, pp. 128–138, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Sharma, R. T. Ownbey, and M. C. Sharma, “Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation,” Experimental and Molecular Pathology, vol. 88, no. 2, pp. 278–286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. C. Sharma and M. Sharma, “The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target,” Current Pharmaceutical Design, vol. 13, no. 35, pp. 3568–3575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Morel and J. Gruenberg, “The p11/S100A10 light chain of annexin A2 is dispensable for annexin A2 association to endosomes and functions in endosomal transport,” PLoS ONE, vol. 2, no. 10, Article ID e1118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Emans, J.-P. Gorvel, C. Walter et al., “Annexin II is a major component of fusogenic endosomal vesicles,” Journal of Cell Biology, vol. 120, no. 6, pp. 1357–1369, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. E. B. Babiychuk and A. Draeger, “Annexins in cell membrane dynamics. Ca2+-regulated association of lipid microdomains,” The Journal of Cell Biology, vol. 150, no. 5, pp. 1113–1124, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. N. A. Lokman, M. P. Ween, M. K. Oehler, and C. Ricciardelli, “The role of annexin A2 in tumorigenesis and cancer progression,” Cancer Microenvironment, vol. 4, no. 2, pp. 199–208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Zhang, S. Liu, C. Guo, J. Zong, and M.-Z. Sun, “The association of annexin A2 and cancers,” Clinical and Translational Oncology, vol. 14, no. 9, pp. 634–640, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Zhang, L. Zhang, B. Zhang et al., “Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells,” Journal of Proteome Research, vol. 8, no. 11, pp. 5041–5047, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Wu, F. Zhang, M. Yu et al., “Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells,” Cell Proliferation, vol. 45, no. 3, pp. 189–198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Shiozawa, A. M. Havens, Y. Jung et al., “Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer,” Journal of Cellular Biochemistry, vol. 105, no. 2, pp. 370–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-X. Wang, H. Lv, Z.-X. Li, C. Li, and X.-Y. Wu, “Effect of shRNA mediated down-regulation of Annexin A2 on biological behavior of human lung adencarcinoma cells A549,” Pathology and Oncology Research, vol. 18, no. 2, pp. 183–190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Singh, H. Wu, C. Clark, and A. Owlia, “Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells,” Oncogene, vol. 26, no. 3, pp. 425–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Guzmán-Aránguez, N. Olmo, J. Turnay et al., “Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5,” Journal of Cellular Biochemistry, vol. 94, no. 1, pp. 178–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Grewal and C. Enrich, “Annexins—modulators of EGF receptor signalling and trafficking,” Cellular Signalling, vol. 21, no. 6, pp. 847–858, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. L. Ackland, D. F. Newgreen, M. Fridman et al., “Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells,” Laboratory Investigation, vol. 83, no. 3, pp. 435–448, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. P. K. Shetty, S. I. Thamake, S. Biswas, S. L. Johansson, and J. K. Vishwanatha, “Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer,” PLoS ONE, vol. 7, no. 9, Article ID e44299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Balanis, M. K. Wendt, B. J. Schiemann, Z. Wang, W. P. Schiemann, and C. R. Carlin, “Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway,” The Journal of Biological Chemistry, vol. 288, no. 25, pp. 17954–17967, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Wang, J. Yuan, J. Zhang et al., “Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells,” Oncotarget, vol. 6, no. 31, pp. 30975–30992, 2015. View at Google Scholar
  28. Y. Q. Wang, F. Zhang, R. Tian et al., “Tyrosine 23 phosphorylation of annexin A2 promotes proliferation, invasion, and stat3 phosphorylation in the nucleus of human breast cancer SK-BR-3 cells,” Cancer Biology & Medicine, vol. 9, pp. 248–253, 2012. View at Google Scholar
  29. T. Morikawa, Y. Baba, M. Yamauchi et al., “STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers,” Clinical Cancer Research, vol. 17, no. 6, pp. 1452–1462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Sanchez-Lopez, E. Flashner-Abramson, S. Shalapour et al., “Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling,” Oncogene, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Jarnicki, T. Putoczki, and M. Ernst, “Stat3: linking inflammation to epithelial cancer—more than a gut feeling?” Cell Division, vol. 5, article 14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Z. Kamran, P. Patil, and R. P. Gude, “Role of STAT3 in cancer metastasis and translational advances,” BioMed Research International, vol. 2013, Article ID 421821, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus